A clinical trial assessing safety, tolerability and efficacy of a combination of narmafotinib with the chemotherapy regime FOLFIRINOX
Latest Information Update: 16 Apr 2025
At a glance
- Drugs Narmafotinib (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Therapeutic Use
Most Recent Events
- 09 Apr 2025 According to Amplia Therapeutics media release, company has announced that trial initiation activities for the planned pancreatic cancer trial in the US have begun.
- 03 Mar 2025 According to Amplia Therapeutics media release, Following a Type D meeting with the United States Food and Drug Administration (FDA), the company has received feedback on proposed modifications to our US clinical trial protocol for narmafotinib.
- 24 Jan 2024 New trial record